CRISPR gene-editing therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CRISPR gene-editing therapy, covering 2026-02-17 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE) [EARLY_Phase 1]